Delivery Order 36F79726D0181-36C24526N0835
Award Date 8/25/26
Potential Completion Date 8/27/26
Potential Value $35K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Carrollton, TX 75010, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Takeda Pharmaceuticals America Inc., a subsidiary of Japan-based Takeda Pharmaceutical Company Limited, received a $48.6K delivery order from Veterans Integrated Service Network 20 (VISN 20) on October 3, 2024, for the supply of ADZYNMA 1500IU injectable lyophilized medication. The award is structured as a firm fixed-price delivery order under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB) with no set-aside designation, reflecting the specialized and limited-source nature of the...
- On November 7, 2025, the Department of Veterans Affairs, Veterans Integrated Service Network 5, awarded a firm fixed-price delivery order valued at $36,984.28 to Takeda Pharmaceuticals America Inc. for the supply of TAKHZYRO 150 MG, a specialized pharmaceutical treatment for hereditary angioedema. This delivery order represents a child contract under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB) and carries an ultimate completion date of November 13, 2025. The award was made without a...
- The Department of Justice Bureau of Prisons Federal Correctional Institution Fort Worth awarded a firm fixed-price delivery order to Takeda Pharmaceuticals America Inc., a subsidiary of Japanese pharmaceutical company Takeda Pharmaceutical Company Limited, to provide various specialty drug products through the Pharmaceuticals and Drugs General Services Administration (GSA) Schedule contract. The $124,865.40 order covers a range of critical medications used to treat conditions such as hemophilia,...
- On December 16, 2025, the Department of Veterans Affairs Veterans Integrated Service Network 5 awarded a firm fixed-price delivery order valued at $36,984.28 to Takeda Pharmaceuticals America Inc. for the supply of TAKHZYRO 150 mg, a specialized pharmaceutical treatment for hereditary angioedema. This delivery order represents a child contract under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB) and carries an ultimate completion date of December 18, 2025. The contract was awarded...
- On February 5, 2026, the Department of Veterans Affairs, Veterans Integrated Service Network 5, awarded a delivery order valued at $38,097.52 to Takeda Pharmaceuticals America Inc. for the supply of TAKHZYRO 150 MG, a specialized pharmaceutical treatment for rare genetic disorders. This firm fixed-price delivery order is issued under a parent Blanket Purchase Agreement established on the General Services Administration Pharmaceuticals and Drugs Schedule (FSS-61-IB), which provides streamlined...
- Takeda Pharmaceuticals America, Inc. has been awarded a $27,913.44 delivery order against its multiple-award Government Services Administration (GSA) Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20. The order is for ICLUSIG 15MG tablets to be delivered to a place of performance in Earth City, Missouri by April 12, 2024. The contract utilizes a firm fixed price payment...
- The Department of Veterans Affairs Veterans Health Administration awarded Takeda Pharmaceuticals America Inc. a $36,101.68 firm fixed price delivery order against the company's GSA Schedule contract for Pharmaceuticals and Drugs. The delivery order is for TAKHZYRO 150MG/ML SYRINGE 2ML SYRINGE (2) to be supplied to Veterans Integrated Service Network 9, with performance taking place in Lexington, Massachusetts from September 6-7, 2023. As the prime contractor, Takeda Pharmaceuticals America...
- The Department of Veterans Affairs Veterans Health Administration awarded a $13,043 delivery order against Takeda Pharmaceuticals America, Inc.'s Pharmaceuticals and Drugs GSA Schedule contract number FSS-61-IB. Under this firm fixed price order, Takeda will provide 30mg doses of the drug ICLUSIG to support the VA's healthcare programs within Veterans Integrated Service Network 5. Performance will occur at Takeda's facility in Earth City, Missouri over a period of four days beginning November...
- The Department of Justice Bureau of Prisons Federal Correctional Institution Fort Worth has awarded a firm fixed-price delivery order to Takeda Pharmaceuticals America Inc., a subsidiary of Takeda Pharmaceutical Company Limited, for medications valued at $98,465.40. The delivery order is placed against Takeda's Pharmaceuticals and Drugs General Services Administration (GSA) Federal Supply Schedule contract. Takeda specializes in providing specialty pharmaceutical products, including treatments...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed-price delivery order to Takeda Pharmaceuticals America Inc. under the company's Pharmaceuticals and Drugs GSA Schedule contract. The $36,890.40 order is for the specialty pharmaceutical product TAKHZYRO 150MG ML SYRINGE 2ML PER SYRINGE, which is used to treat hereditary angioedema. The delivery order has an April 2024 completion date and will support patient care programs across the VA's Veterans...